Inflectra® ,
Infliximab-dyyb
Disease
Crohn's disease
,
Ulcerative colitis
,
Drug Class
Biologics/Biosimilars
Delivery Method
IV
or
Brand name:
Inflectra®
(This drug is a biosimilar to Remicade©)
,Drug name:
Infliximab-dyyb
Drug type
Anti-TNF
Recommendations for pregnancy
Low risk
Recommendations for breastfeeding
Limited human data: probably compatible
Most common side effects
Common side effects include respiratory infections (sinus infections or sore throat), headache, coughing, and stomach pain.
Other
Serious infections have included tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body or cause infections in certain areas. Lymphoma, including hepatosplenic T-cell lymphoma, and other cancers, have also been reported.
Learn more about
Biologics/Biosimilars